Please use this identifier to cite or link to this item:
|Title:||Physiological basis behind ergogenic effects of anabolic androgens.|
|Authors:||Cheung, Ada S;Grossmann, Mathis|
|Affiliation:||Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia|
Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia
|Citation:||Molecular and cellular endocrinology 2018; 464: 14-20|
|Abstract:||Anabolic androgenic steroids (AAS) are widely abused by the sporting community. Demonstrating performance enhancing effects of AAS in rigorous scientific studies is fraught with difficulty. In controlled studies, AAS have consistently been reported to increase muscle mass and strength. The clinical evidence that these anabolic effects are independent of, and additive to exercise are supported by preclinical studies suggesting that AAS and exercise affect muscle by overlapping, yet distinct mechanisms. AAS may also improve performance by their actions on other organ systems, such as the vasculature, and the erythropoietic and central nervous system, although this evidence is less strong. While most of the actions of AAS are thought to be mediated via classical androgen receptor-mediated genomic signalling, AAS may also produce rapid effects via non-genomic mechanisms.|
|Subjects:||Anabolic androgenic steroids|
Androgen receptor signalling
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.